XML 116 R84.htm IDEA: XBRL DOCUMENT v3.22.2.2
Dispositions (Details Textual)
$ in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Apr. 30, 2022
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Jan. 31, 2022
USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Gain on sale of equity interest in Samsung Bioepis     $ (1,505.4) $ 0.0  
Samsung Bioepis          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Equity, ownership interest   49.90% 49.90%    
Samsung Bioepis | Fair Value, Recurring          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Other current assets, receivable   $ 790.8 $ 790.8    
Other assets, receivable   $ 402.8 $ 402.8    
Samsung Bioepis | Payment Due At First Anniversary | Discount rate | Fair Value, Recurring          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Risk-adjusted discount rates   0.049 0.049    
Samsung Bioepis | Payment Due At Second Anniversary | Discount rate | Fair Value, Recurring          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Risk-adjusted discount rates   0.053 0.053    
Samsung Bioepis          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Proceeds from divestiture of interest in joint venture $ 1,000.0        
Payables to divestiture of interest in joint venture         $ 1,300.0
Gain on sale of equity interest in Samsung Bioepis     $ 1,500.0    
Cumulative translation loss     58.9    
Gain on derivative used in net investment hedge     57.0    
Gain (loss) on sale   $ 2.7 (4.0)    
Additional milestone payment $ 50.0        
Contingent discount on common shares 5.00%        
Discrete income tax expense (benefit)   $ 258.3 $ 258.3    
Samsung Bioepis | Payment Due At First Anniversary          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Payables to divestiture of interest in joint venture         812.5
Samsung Bioepis | Payment Due At Second Anniversary          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Payables to divestiture of interest in joint venture         $ 437.5